Black Rock Inc. Argenx Se Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Argenx Se stock. As of the latest transaction made, Black Rock Inc. holds 1,011,291 shares of ARGX stock, worth $918 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,011,291
Previous 1,047,289
3.44%
Holding current value
$918 Million
Previous $412 Million
5.47%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ARGX
# of Institutions
524Shares Held
26MCall Options Held
590KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Avoro Capital Advisors LLC New York, NY990KShares$899 Million9.98% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...